
Gabriel Zada MD MS, FAANS
Brain & Spinal Tumor, Cerebrovascular Neurosurgery, Pituitary Surgery, Skull Base
Professor of Neurological Surgery Vice Chair of Education Residency Program Director Department of Neurosurgery Keck School of Medicine of USC Editor, Neurosurgical Focus Surgical Director, USC Brain Tumor Center Associate Residency Program Director
Join to view full profile
1520 San Pablo StSte 3800Los Angeles, CA 90033
Phone+1 323-442-5720
Fax+1 323-226-7833
Dr. Zada is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Gabriel Zada, MD, MS, FAANS, FACS, is Professor of Neurological Surgery, Otolaryngology, and Physiology & Neuroscience at the Keck School of Medicine of USC and an internationally recognized leader in brain, skull base, and pituitary tumor surgery. He serves as Vice Chair of Education and Residency Program Director, Surgical Director of the USC Brain Tumor Center, and Director of the USC Endoscopic Skull Base Surgery Program.
Dr. Zada has performed more than 3,000 cranial operations, specializing in minimally invasive and endoscopic approaches for brain, pituitary, and skull base tumors. He completed fellowship training under Dr. Edward Laws at Harvard/Brigham and Women’s Hospital and advanced training under Dr. Paolo Cappabianca in Naples, Italy.
An NIH-funded investigator, Dr. Zada has authored more than 400 peer-reviewed publications and 3 surgical textbooks. He is Editor of *Neurosurgical Focus* and President-Elect of the AANS/CNS Joint Section on Tumors. FindExpertMD ranks him the **#1 neurosurgeon in California for pituitary tumors, meningiomas, skull base neoplasms, and neuroendoscopy**.
Education & Training
University of Southern CaliforniaM.S., Clinical and Biomedical Investigation, 2015
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Neurological Surgery, 2004 - 2011
Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Cerebrovascular & Skull Base Surgery, 2009 - 2010
University of California San Francisco School of MedicineClass of 2004
University of California, BerkeleyB.A., Molecular and Cell Biology Emphasis in Neurobiology, with Honors, 2000
Certifications & Licensure
CA State Medical License 2006 - 2027
American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2015-2017
Clinical Trials
Publications & Presentations
PubMed
- Sex and Age Differences in Transcription Factor and Hormonal Immunostaining in Patients With Nonfunctioning Pituitary Adenomas.Amara Emeh, Erica Gillespie, David J Cote, Apurva Prasad, William Zeng
Operative Neurosurgery. 2026-11-01 - 1 citationsT2-Weighted MRI Signal Intensity Ratio Predicts Intraoperative Intracranial Meningioma Consistency: A Retrospective Cohort Study.Ishan Shah, David Gomez, Kevin G Liu, David J Cote, Robert G Briggs
Neurosurgery. 2026-11-01 - Optimizing inferior petrosal sinus sampling: results of a multicenter study.Clayton Rawson, Samuel A Tenhoeve, Julie M Silverstein, Albert H Kim, James J Evans
Journal of Clinical Neuroscience. 2026-10-27
Journal Articles
- Complications Associated with Microscopic and Endoscopic Transsphenoidal Pituitary Surgery: Experience of 1153 Consecutive Cases Treated at a Single Tertiary Care Pitu...Matthew S Agam, Michelle A Wedemeyer, Gabriel Zada, Journal of Neurosurgery
- Outcomes Following Transsphenoidal Surgical Management of Incidental Pituitary Adenomas: A Series of 52 Patients over a 17-Year Period RelatedMichelle A Wedemeyer, Gabriel Zada, Journal of Neurosurgery
- Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicityDiao K, Bian SX, Routman DM, Yu C, Ye JC, Wagle NA, Wong MK, Zada G, Chang EL, J Neuro-Oncology, 1/25/2018
Books/Book Chapters
Abstracts/Posters
- Meta-analysis of the efficacy and safety of therapeutic hypothermia in children with acute traumatic brain injury.Gadkary C, Zada G, Quinones-Hinojosa A, World Neurosurgery, 1/1/2015
- Spinal Arachniod Cysts in the Pediatric Population: Report of 31 cases and a review of the literature.Bond A, Zada G, Bowen I, McComb JG, Krieger M, Congress of Neurological Surgeons Annual Meeting, Washington, DC, 1/1/2011
- Fetal Diagnosis of Neurosurgical Disease.McNatt S, Zada G, Jackson H, Krieger M, McComb JG, CNS Annual Meeting, San Diego, CA, 1/1/2007
Lectures
- Integrative genomic and epigenomic analysis implicates MYC and MAX in functional pituitary adenomas.New Orleans, LA - 1/1/2018
- Management of Pituitary IncidentalomasUniversity of Southern California, Los Angeles, CA - 1/1/2018
- Modern Techniques in Pituitary SurgeryBoston, MA. 2017; University of Southern California, Los Angeles, CA, 2018 - 1/1/2018
Authored Content
- Outcomes Following Transsphenoidal Surgical Management of Incidental Pituitary Adenomas: A Series of 52 Patients over a 17-Year Period RelatedJune 2018
- Complications Associated with Microscopic and Endoscopic Transsphenoidal Pituitary Surgery: Experience of 1153 Consecutive Cases Treated at a Single Tertiary Care Pituitary Center RelatedJune 2018
- In Reply to “Neurosurgery Elective for Preclinical Medical Students: 6-Year Follow-Up”February 2018
Press Mentions
Mapping Genetic Activity Offers New Clues for Personalized Cancer TreatmentJune 12th, 2025
We All Bump Our Heads Once in a While, but When Does a Head Injury Require Medical Attention? Doctors ExplainFebruary 16th, 2022
Science News | Research Sheds Light on How Brain Metastasis OccursSeptember 25th, 2021
Grant Support
- Noninvasive transcranial detection of intracranial hemorrhage using a tri-coil handheld portable eddy current damping imaging deviceUNIVERSITY OF SOUTHERN CALIFORNIA2021–2025
- DNA Methylation and gene expression variations influence pituitary adenoma hormonal function and invasive growth NIH (National Cancer Institute)2018–2023
Professional Memberships
- Member
- Member
- NASBSMember
Other Languages
- Spanish, Hebrew
External Links
- Dr. Zada USC Pagehttps://providers.keckmedicine.org/provider/Gabriel+Zada/205197
- Dr. Zada's Personal Websitehttp://www.drzada.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:




